Efficacy and clinicogenomic correlates of response to immune checkpoint inhibitors alone or with chemotherapy in non-small cell lung cancer
2023 · Nature Communications · 53 citations
https://doi.org/10.1038/s41467-023-36328-z
P
Pingjun Chen
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
75
Papers
1.5K
Citations
19
h-index
24
i10-index
Pingjun Chen is an academic researcher from The University of Texas MD Anderson Cancer Center. The author has contributed to research in topics: Radiomics and Machine Learning in Medical Imaging & AI in cancer detection & Lung Cancer Diagnosis and Treatment. The author has an h-index of 19, co-authored 64 publications.
ORCID: 0000-0003-0528-1713Papers by this author
worksPathomic Features Reveal Immune and Molecular Evolution From Lung Preneoplasia to Invasive Adenocarcinoma
2023 · Modern Pathology · 31 citations
https://doi.org/10.1016/j.modpat.2023.100326
Synthetic PET from CT improves diagnosis and prognosis for lung cancer: Proof of concept
2024 · Cell Reports Medicine · 27 citations
https://doi.org/10.1016/j.xcrm.2024.101463
CellSpatialGraph: Integrate hierarchical phenotyping and graph modeling to characterize spatial architecture in tumor microenvironment on digital pathology
2021 · Software Impacts · 4 citations
https://doi.org/10.1016/j.simpa.2021.100156
Demo Whole Slide Images
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7532978.v2
Whole Slide Image Samples
2018 · Figshare · 0 citations
https://doi.org/10.6084/m9.figshare.7532978
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat